Appendix B
Persons Who Were Interviewed by Committee or Staff or Who Provided Written Materials
Ronald Abeles, National Institute on Aging, NIH1
Donald Abrams, Assistant Director, AIDS Activities, San Francisco General Hospital
Donna Adderly, Office of the Director, NIH
Reid Adler, Office of Technology Transfer, NIH
Duane Alexander, National Institute of Child Health and Human Development, NIH
James Allen, National AIDS Program Office, Department of Health and Human Services
John Bader, National Cancer Institute, NIH
Barbara Baird, Clinical Center, NIH
Wendy Baldwin, National Institute of Child Health and Human Development, NIH
James Balsley, National Institute of Allergy and Infectious Diseases, NIH
Steven J. Berkowitz, National Institute of Allergy and Infectious Diseases, NIH
Bernard Bihari, Community Research Initiative2
William Blattner, National Cancer Institute, NIH
William Borkowsky, New York University Medical Center
Bernard Branson, Physicians Association for AIDS Care3
Sandra Bridges, National Institute of Allergy and Infectious Diseases, NIH
Samuel Broder, National Cancer Institute, NIH
James W. Buehler, Centers for Disease Control
Virginia Cain, National Institute of Child Health and Human Development, NIH
Marvin Cassman, National Institute of General Medical Sciences, NIH
Bruce Chabner, National Cancer Institute, NIH
Eileen Chusid, Mt. Sinai Medical Center
Edward Connor, Children's Hospital of New Jersey
Ellen Cooper, Food and Drug Administration
Lawrence Corey, University of Washington School of Medicine
Deborah Cotton, Harvard School of Public Health
Charles L. Coulter, National Center for Research Resources, NIH
George Counts, National Institute of Allergy and Infectious Diseases, NIH
1 |
The affiliation provided for each individual is at time of interview or receipt of material. |
2 |
Submitted written testimony to committee. |
3 |
Testified before committee, December 4–5, 1989. |
James Cradock, National Institute of Allergy and Infectious Diseases, NIH
James W. Curran, Centers for Disease Control
William N. Darrow, Centers for Disease Control
Martin Delaney, Project Inform3
Lawrence Deyton, National Institute of Allergy and Infectious Diseases, NIH
Patrice Edwards, Albert Einstein College of Medicine
Susan Ellenberg, National Institute of Allergy and Infectious Diseases, NIH
John Fahey, University of California at Los Angeles Medical Center
Anthony Fauci, National Institute of Allergy and Infectious Diseases, NIH
Judith Feinberg, National Institute of Allergy and Infectious Diseases, NIH
Patricia Fleming, Congressional Office of Representative Ted Weiss
Lorraine Fishback, Office of the Assistant Secretary for Health, Dpeartment of Health and Human Services
Michael Friedman, National Cancer Institute, NIH
George J. Galasso, Office of the Director, NIH
William Gartland, National Institute of Allergy and Infectious Diseases, NIH
Jacob A. Gayle, Centers for Disease Control
Ronald Geller, National Heart, Lung, and Blood Institute, NIH
Clarence Gibbs, National Institute of Neurological Diseases and Stroke, NIH
James J. Goedert, National Cancer Institute, NIH
Michael Goldrich, National Institute of Allergy and Infectious Diseases, NIH
William H. Goldwater, Office of the Director, NIH
Edward Gomperts, Children's Hospital of Los Angeles
Rosalind Gray, Office of the Director, NIH
Edward Gubish, National Institute of Allergy and Infectious Diseases, NIH
Kurt Habel, Office of the Director, NIH
Maya Hadar, National Institute of Allergy and Infectious Diseases, NIH
Margaret Hamburg, National Institute of Allergy and Infectious Diseases, NIH
John Hartinger, National Cancer Institute, NIH
Peter Hartsock, Alcohol, Drug, and Mental Health Administration
Suzanne Haynes, National Cancer Institute, NIH
Janet Heinrich, National Center for Nursing Research, NIH
Ada Sue Hinshaw, National Center for Nursing Research, NIH
Martin Hirsch, Harvard Medical School
Patricia Hoban, Office of the Assistant Secretary for Health
June Horner, Health Resources and Services Administration
Marc Horowitz, Office of AIDS Research, NIH
Daniel Hoth, National Institute of Allergy and Infectious Diseases, NIH
Peter Barton Hutt, Law firm of Covington and Burling
John C. James, Division of Research Grants, NIH
Stephanie James, National Institute of Allergy and Infectious Diseases, NIH
John Jarman, Office of the Director, NIH
Leslye D. Johnson, National Institute of Allergy and Infectious Diseases, NIH
Margaret Johnston, National Institute of Allergy and Infectious Diseases, NIH
Anthony Kalica, National Heart, Lung, and Blood Institute, NIH
Richard Kaslow, National Institute of Allergy and Infectious Diseases, NIH
Deborah Katz, National Institute of Allergy and Infectious Diseases, NIH
Stan Katzman, Office of AIDS Research, NIH
Jack Killen, National Institute of Allergy and Infectious Diseases, NIH
Jane Kinsel, National Institute of Allergy and Infectious Diseases, NIH
David L. Klein, National Institute of Allergy and Infectious Diseases, NIH
Wayne Koff, National Institute of Allergy and Infectious Diseases, NIH
Lloyd J. Kolbe, Centers for Disease Control
Richard M. Krause, Fogarty International Center, NIH
Michon Kretschmaier, Office of the Assistant Secretary for Health, Department of Health and Human Services
Clifford Lane, National Institute of Allergy and Infectious Diseases, NIH
Elaine Larson, American Nurses' Association3
Catherine Laughlin, National Institute of Allergy and Infectious Diseases, NIH
Barbara Laughon, National Institute of Allergy and Infectious Diseases, NIH
Missy LeClaire, National Association of People With AIDS3
Claude Lenfant, National Heart, Lung, and Blood Institute, NIH
Norman Letvin, New England Primate Center
Carl Leventhal, National Institute of Neurological Diseases and Stroke, NIH
Wendy Liffers, National Institute of Allergy and Infectious Diseases, NIH
Charles Litterst, National Institute of Allergy and Infectious Diseases, NIH
Iris Long, AIDS Treatment Registry3
Claire Macklan, Agency for Health Care Policy and Research
John D. Mahoney, Office of the Director, NIH
Barbara Masters, Congressional Office of Senator Alan Cranston
Henry Masur, Clinical Center, NIH
Samuel Matheny, Health Resources and Services Administration
Bruce Maurer, Division of Research Grants, NIH
John McGowan, National Institute of Allergy and Infectious Diseases, NIH
Jean McGuire, AIDS Action Council3
Merle McPherson, Health Resources and Services Administration
Gerald Medoff, Washington University School of Medicine
Gilbert Meier, Division of Research Grants, NIH
Mike Meridian, National Association of People With AIDS3
Thomas Merigan, Stanford University School of Medicine
Abbey S. Meyers, National Organization for Rare Disorders3
Michael Miller, Office of AIDS Research, NIH
Richard Miller, Office of the Director, NIH
John Mills, San Francisco General Hospital
Greg Milman, National Institute of Allergy and Infectious Diseases, NIH
Janet Mitchell, National Minority AIDS Council3
Horoaki Mitsuya, National Cancer Institute, NIH
John La Montagne, National Institute of Allergy and Infectious Diseases, NIH
W. Meade Morgan, Centers for Disease Control
Richard Mowery, National Eye Institute, NIH
Jay Moskowitz, Office of the Director, NIH
Maureen Myers, National Institute of Allergy and Infectious Diseases, NIH
Marti Nash, San Francisco General Hospital
Antonia Novello, National Institute of Child Health and Human Development, NIH
Joyce O'Shaughnessy, National Cancer Institute, NIH
John Petricciani, Pharmaceutical Manufacturers Association
Carla Pettinelli, National Institute of Allergy and Infectious Diseases, NIH
Pharmaceutical company representatives (spoke on condition of anonymity)
Philip Pizzo, National Cancer Institute, NIH
William Powderly, Washington University School of Medicine
Patricia Randall, National Institute of Allergy and Infectious Diseases, NIH
Matilda Riley, National Institute on Aging, NIH
Dennis Rodriguez, Office of AIDS Research, NIH
Karyn Ross, National Institute on Aging, NIH
Henry Sacks, Mount Sinai School of Medicine
Polly Sager, National Institute of Allergy and Infectious Diseases, NIH
Robert T. Schooley, Massachusetts General Hospital
Lewis Schrager, National Institute of Allergy and Infectious Diseases, NIH
Neil Schram, AIDS Task Force, American Association of Physicians for Human Rights3
Daniela Seminara, Alcohol, Drug, and Mental Health Administration
Valerie Setlow, National AIDS Program Office, Department of Health and Human Services
Hilary Sigmund, National Center for Nursing Research, NIH
Elaine Sloand, National Heart, Lung, and Blood Institute, NIH
Steve Smith, Human Rights Campaign Fund3
Ruy Soeiro, Albert Einstein College of Medicine
Mike Stephens, House of Representatives Appropriations Subcommittee Staff
Allen C. Stoolmiller, National Institute of Allergy and Infectious Diseases, NIH
Judith Swan, Office of AIDS Research, NIH
Jose Szapocznik, University of Miami
Lawrence Thompson, Washington Post
Melanie Thompson, Atlanta AIDS Research Consortium
Cherry Tsutsumida, Health Resources and Services Administration
Judith Vaitukaitis, National Center for Research Resources, NIH
Sten Vermund, National Institute of Allergy and Infectious Diseases, NIH
Thomas Voskuhl, National Institute of Allergy and Infectious Diseases, NIH
Paul Wade, National Center for Research Resources, NIH
Huber Warner, National Institute on Aging, NIH
Judith Wasserheit, National Institute of Allergy and Infectious Diseases, NIH
Diane S. Wax, National Institute of Allergy and Infectious Diseases, NIH
Tim Westmoreland, House Subcommittee on Health and Environment Staff
Judith Whalen, National Cancer Institute, NIH
Jack Whitescarver, Office of AIDS Research, NIH
Richard Whitley, University of Alabama
Anne Willoughby, National Institute of Child Health and Human Development, NIH